Expression level of PU.1 was decreased in USP22-deficient KRAS-induced myeloproliferative neoplasm mice (KMUKO) as compared to the KRAS-induced myeloproliferative neoplasm mice (KM) [122]. Here, USP22 is linked to myeloproliferative disorder.